Cargando…
P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171775/ http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90 |
_version_ | 1785039495273381888 |
---|---|
author | Groen, K. Stege, C. Nasserinejad, K. de Heer, K. van Kampen, R. Leys, R. Thielen, N. Westerman, M. Wu, K. Ludwig, I. Issa, D. Velders, G. Vekemans, M. van de Donk, N. Timmers, G. de Boer, F. Tick, L. van der Spek, E. de Waal, E. Sohne, M. Sonneveld, P. Nijhof, I. Klein, S. Levin, M. Ypma, P. Zweegman, S. |
author_facet | Groen, K. Stege, C. Nasserinejad, K. de Heer, K. van Kampen, R. Leys, R. Thielen, N. Westerman, M. Wu, K. Ludwig, I. Issa, D. Velders, G. Vekemans, M. van de Donk, N. Timmers, G. de Boer, F. Tick, L. van der Spek, E. de Waal, E. Sohne, M. Sonneveld, P. Nijhof, I. Klein, S. Levin, M. Ypma, P. Zweegman, S. |
author_sort | Groen, K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10171775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101717752023-05-11 P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY Groen, K. Stege, C. Nasserinejad, K. de Heer, K. van Kampen, R. Leys, R. Thielen, N. Westerman, M. Wu, K. Ludwig, I. Issa, D. Velders, G. Vekemans, M. van de Donk, N. Timmers, G. de Boer, F. Tick, L. van der Spek, E. de Waal, E. Sohne, M. Sonneveld, P. Nijhof, I. Klein, S. Levin, M. Ypma, P. Zweegman, S. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171775/ http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Poster Groen, K. Stege, C. Nasserinejad, K. de Heer, K. van Kampen, R. Leys, R. Thielen, N. Westerman, M. Wu, K. Ludwig, I. Issa, D. Velders, G. Vekemans, M. van de Donk, N. Timmers, G. de Boer, F. Tick, L. van der Spek, E. de Waal, E. Sohne, M. Sonneveld, P. Nijhof, I. Klein, S. Levin, M. Ypma, P. Zweegman, S. P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title | P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title_full | P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title_fullStr | P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title_full_unstemmed | P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title_short | P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
title_sort | p13 ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma; results of the induction and maintenance treatment of the phase ii hovon 143 study |
topic | Poster |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171775/ http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90 |
work_keys_str_mv | AT groenk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT stegec p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT nasserinejadk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT deheerk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vankampenr p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT leysr p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT thielenn p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT westermanm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT wuk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT ludwigi p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT issad p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT veldersg p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vekemansm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vandedonkn p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT timmersg p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT deboerf p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT tickl p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vanderspeke p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT dewaale p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT sohnem p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT sonneveldp p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT nijhofi p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT kleins p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT levinm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT ypmap p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT zweegmans p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study |